Challenge: The client is a leading pharmaceutical company in China, with steadily growing sales revenue in recent years but lacking core competitiveness. They aim to create more value from their existing sales channels, expand into overseas markets, and maximize the value of their premium products. The client is looking to acquire a U.S. company to produce high-quality health supplements and promote their products internationally. However, they lack a clear estimate of the growth potential and value of the target overseas market and have limited experience negotiating with business and trade partners.
Solution: We analyzed epidemiological data, clinical practices, market trends, product pricing, and market share to forecast the product’s sales performance in overseas markets. By referencing the pricing of similar products in the target market, we assessed price sensitivity to provide an initial pricing recommendation for the local market entry and forecast price changes over the next few years. Through an evaluation of projected sales performance, clinical and marketing costs, we estimated the product’s value range between 1,500K to 5,000K USD and proposed a suitable business structure.
Outcome: Considering the value of the client’s product, we provided a list of potential partners within the U.S. health supplement industry for collaboration on the client’s production line. The negotiation evidence and communication channels we supplied enabled the client to successfully engage in discussions with U.S. companies. The target product is expected to enrich the client’s product line and help expand their business in the U.S. market, generating an estimated $1 million in revenue within three years.